3fq9
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
- | [[Image:3fq9. | + | [[Image:3fq9.png|left|200px]] |
<!-- | <!-- | ||
Line 12: | Line 12: | ||
===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_19773552}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 19773552 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_19773552}} | ||
==About this Structure== | ==About this Structure== | ||
3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | 3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:19773552</ref><references group="xtra"/> | ||
[[Category: Katsoyannis, P.]] | [[Category: Katsoyannis, P.]] | ||
[[Category: Phillips, N.]] | [[Category: Phillips, N.]] | ||
Line 37: | Line 46: | ||
[[Category: Therapeutic implication]] | [[Category: Therapeutic implication]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 25 09:31:43 2009'' |
Revision as of 07:31, 25 November 2009
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Template:ABSTRACT PUBMED 19773552
About this Structure
3FQ9 is a 4 chains structure. Full crystallographic information is available from OCA.
Reference
- Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 doi:10.1074/jbc.M109.028399
Page seeded by OCA on Wed Nov 25 09:31:43 2009
Categories: Katsoyannis, P. | Phillips, N. | Wan, Z L. | Weiss, M A. | Whittaker, J. | Whittaker, L. | Xu, B. | Zhao, M. | Carbohydrate metabolism | Cleavage on pair of basic residue | Diabetes mellitus | Disease mutation | Glucose metabolism | Hormone | Insulin design | Pharmaceutical | Rational | Receptor-binding | Secreted | Structure | Therapeutic implication